Leukotrienes produced in allergic lung inflammation activate alveolar macrophages

Cellular Physiology and Biochemistry

Volumn 26, Issue 3, 2010, Pages 319-326

  Silva, Reinaldo C ^a   Landgraf, Maristella A ^b   Hiyane, Meire I ^b   Pacheco Silva, Alvaro ^a   Câmara, Niels O ^a,b   Landgraf, Richardt G ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Alveolar macrophages; Asthma; Killing; Klebsiella pneumoniae; Leukotrienes

Indexed keywords

FC RECEPTOR; LEUKOTRIENE; LEUKOTRIENE C4; LEUKOTRIENE D4; MONTELUKAST; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; ARTICLE; ASTHMA; CONTROLLED STUDY; ENZYME IMMUNOASSAY; EOSINOPHIL COUNT; ERYTHROCYTE; KLEBSIELLA PNEUMONIAE; LUNG ALVEOLUS MACROPHAGE; LUNG LAVAGE; MACROPHAGE FUNCTION; MALE; NEUTROPHIL COUNT; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; RAT;

ANIMALIA; KLEBSIELLA PNEUMONIAE; RATTUS; RATTUS NORVEGICUS;

EID: 78650016933     PISSN: 10158987     EISSN: None     Source Type: Journal    
DOI: 10.1159/000320555     Document Type: Article

References (41)

1. Miyake Y, Kaise H, Isono K, Koseki H, Kohno K, Tanaka M: Protective Role of Macrophages in Noninflammatory Lung Injury Caused by Selective Ablation of Alveolar Epithelial Type II Cells. J Immunol 2007;178:5001-5009.
2. Serezani CH, Aronoff DM, Jancar S, Mancuso P, Peters-Golden M: Leukotrienes enhance the bactericidal activity of alveolar macrophages against Klebsiella pneumoniae through the activation of NADPH oxidase. Blood 2005;106:1067-1075.
3. Mancuso P, Standiford TJ, Marshall T, Peters-Golden M: 5-Lipoxygenase reaction products modulate alveolar macrophage phagocytosis of Klebsiella pneumoniae. Infect Immun 1998;66:5140-5146.
4. Serhan C N, Radin A, Smolen JE, Korchak H, Samuelsson B, Weissmann G: Leukotriene B4 is a complete secretagogue in human neutrophils: a kinetic analysis. Biochem Biophys Res Commun 1982;107:1006-1012.
5. 4 . J Immunol 1999;163:6148-6154.
6. Mancuso P, Huffnagle GB, Olszewski MA, Phipps J, Peters-Golden M: Leptin corrects host defense defects after acute starvation in murine pneumococcal pneumonia. Am J Respir Crit Care Med 2006;173:212-218.
7. Serezani CH, Perrela JH, Russo M, Peters-Golden M, Jancar S: Leukotrienes are essential for the control of Leishmania amazonensis infection and contribute to strain variation in susceptibility. J Immunol 2006;177:3201-3208.
8. Medeiros AI, Sá-Nunes A, Soares EG, Peres CM, Silva CL, Faccioli LH: Blockade of endogenous leukotrienes exacerbates pulmonary histoplasmosis. Infect Immun 2004;72:1637-1644.
9. Duroudier NP, Tulah AS, Sayers I: Leukotriene pathway genetics and pharmacogenetics in allergy. Allergy 2009;64:823-839.
10. Riccione G, Zanasi A, Vitulano N, Mancini B, D'Orazio N: Leukotrienes in atherosclerosis: New target insights and future therapy perpectives. Mediators Inflamm 2009;2009:737282
11. Landgraf RG, Nossi DF, Sirois P, Jancar S: Prostaglandins, leukotrienes and PAF selectively modulate lymphocyte subset and eosinophil infiltration into the airways in a murine model of asthma. Prostaglandins Leukot Essent Fatty Acids 2007;77:163-172.
12. Ohnishi H, Miyahara N, Gelfand EW: The Role of Leukotriene B(4) in Allergic Diseases. Allergol Int 2008;57:291-8.
13. Peters-Golden M, Gleason MM, Togias A: Cysteinyl leukotrienes: multifunctional mediators in allergic rhinitis. Clin Exp Allergy 2006;36:689-703.
14. De Graaf-in t Veld C, Garrelds IM, Koenders S, Gerth van Wijk R: Relationship between nasal hyperreactivity, mediators and eosinophils in patients with perennial allergic rhinitis and controls. Clin Exp Allergy. 1996;26:903-908.
15. Wang D, Duyck F, Smitz J, Clement P: Efficacy and onset of action of fluticasone propionate aqueous nasal spray on nasal symptoms, eosinophil count, and mediator release after nasal allergen challenge in patients with seasonal allergic rhinitis. Allergy 1998;53:375-382.
16. Shirasaki H, Kanaizumi E, Watanabe K, Matsui T, Sato J, Narita S, Rautiainen M, Himi T: Expression and localization of the cysteinyl leukotriene 1 receptor in human nasal mucosa. Clin Exp Allergy 2002;32:1007-1012.
17. Ravetch J V, Bolland S: IgG Fc receptors. Annu Rev Immunol 2001;19:275-290.
18. Araki N, Johnson MT, Swanson JA: A role for phosphoinositide 3-kinase in the completion of macropinocytosis and phagocytosis by macrophages. J Cell Biol 1996;135:1249-1260.
19. Aronoff DM, Canetti C, Serezani CH, Luo M, Peters-Golden M: Cutting edge: macrophage inhibition by cyclic AMP (cAMP): differential roles of protein kinase A and exchange protein directly activated by cAMP-1. J Immunol 2005;174:595-599.
20. Bidani A, Reisner BS, Haque AK, Wen J, Helmer RE, Tuazon DM, Heming TA: Bactericidal activity of alveolar macrophages is suppressed by V-ATPase inhibition. Lung 2000;178:91-104.
21. Prestes-Carneiro LE, Shio MT, Fernandes PD, Jancar S: Cross-regulation of iNOS and COX-2 by its products in murine macrophages under stress conditions. Cell Physiol Biochem 2007;20:283-292.
22. Pradelles P, Grassi J, Maclouf J: Enzyme immunoassays of eicosanoids using acetylcholine esterase as label: an alternative to radioimmunoassay. Anal Chem 1985;57:1170-1173.
23. Ford-Hutchinson AW, Bray MA, Smith MJ: Lipoxygenase products and the polymorphonuclear leucocyte. Agents Actions 1980;10:548-555.
24. Virchow JC, Faehndrich S, Nassenstein C, Bock S, Matthys H, Luttmann W : Effect of a specific cysteinyl leukotrienereceptor 1-antagonist (montelukast) on the transmigration of eosinophils across human umbilical vein endothelial cells. Clin Exp Allergy 2001;31:836-844.
25. Cuzzocrea S, Rossi A, Mazzon E, Di Paola R, Genovese T, Muià C, Caputi A P, Sautebin L: 5-lipoxygenase modulate the development of colitis in mice through the regulation of adhesion molecules expression. Lab Invest 2005;85:808-822.
26. Genovese T, Rossi A, Mazzon E, Di Paola R, Muia C, Caminiti R, Bramanti P, Sautebin L, Cuzzocrea S: Effects of zileuton and montelukast in mouse experimental spinal cord injury. British Journal of Pharmacology 2008;153:568-582.
27. Muñoz N M, Douglas I, Mayer D, Herrnreiter A, Zhu X, Leff AR: Eosinophil chemotaxis inhibited by 5-lipoxygenase blockade and leukotriene receptor antagonism. Am J Respir Crit Care Med 1997;155:1398-1403.
28. Underwood D C, Osborn R R, Newsholme S J, Torphy T J, Hay D W: Persistent airway eosinophilia after leukotriene (LT) D4 administration in the guinea pig: modulation by the LTD4 receptor antagonist, pranlukast, or an interleukin-5 monoclonal antibody. Am J Respir Crit Care Med 1996;154:850-857.
29. Mancuso P, Peters-Golden M: Modulation of alveolar macrophage phagocytosis by leukotrienes is Fc receptor-mediated and protein kinase C-dependent. Am J Respir Cell Mol Biol 2000;23:727-733.
30. Wright SD, Silverstein SC: Receptors for C3b and C3bi promote phagocytosis but not the release of toxic oxygen from human phagocytes. J Exp Med 1983;158:2016-2023.
31. Muniz-Junqueira MI, de Paula-Coelho VN: Meglumine antimonate directly increases phagocytosis, superoxide anion and TNF-α production, but only via TNF-α it indirectly increases nitric oxide production by phagocytes of healthy individuals, in vitro. Int Immunopharmacol 2008;8:1633-1638.
32. Jesch NK, Dorger M, Enders G, Rieder G, Vogelmeier C, Messmer K, Krombach F: Expression of inducible nitric oxide synthase and formation of nitric oxide by alveolar macrophages: an interspecies comparison. Environ Health Perspect 1997;105:1297-1300.
33. Anstey NM, Weinberg JB, Hassanali M Y, Mwaikambo ED, Manyenga D, Misukonis MA, Arnelle DR, Hollis D, Mc-Donald MI, Granger DL: Nitric oxide in Tanzanian children with malaria: inverse relationship between malaria severity and nitric oxide production/ nitric oxide synthase type 2 expression. J Exp Med 1996;184:557-567.
34. Nozaki Y, Hasegawa Y, Ichiyama S, Nakashima I, Shimokata K: Mechanism of nitric oxide-dependent killing of Mycobacterium bovis BCG in human alveolar macrophages. Infect Immun 1997;65:3644-3647.
35. Wang CH, Liu CY, Lin HC, Yu CT, Chung KF, Kuo HP: Increased exhaled nitric oxide in active pulmonary tuberculosis due to inducible NO synthase upregulation in alveolar macrophages. Eur Respir J 1998;11:809-815.
36. Kuo HP, Wang CH, Huang KS, Lin HC, Yu CT, Liu C Y, Lu LC: Nitric oxide modulates interleukin-1beta and tumor necrosis factor-alpha synthesis by alveolar macrophages in pulmonary tuberculosis. Am J Respir Crit Care Med 2000;161:192-199.
37. Fang FC: Perspectives series: host/ pathogen interactions. Mechanisms of nitric oxide-related antimicrobial activity. J Clin Invest 1997;99:2818-2825.
38. Nathan C: Inducible nitric oxide synthase: what difference does it make? J Clin Invest 1997;100:2417-2423.
39. Nathan C, Shiloh MU: Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens. Proc Natl Acad Sci USA 2000;97:8841-8848.
40. Yang SL, Chen LJ, Kong Y, Xu D, Lou YJ: Sodium nitroprusside regulates mRNA expressions of LTC4 synthesis enzymes in hepatic ischemia-reperfusion injury rats via NF-kappaB signaling pathway. Pharmacology 2007;80:11-20.
41. Ko JK, Cho CH: Co-regulation of mucosal nitric oxide and prostaglandin in gastric adaptive cytoprotection. Inflamm Res 1999;48:471-478.